American Renal Associates Holdings Inc (NYSE:ARA) – Equities researchers at SunTrust Banks raised their FY2016 earnings per share (EPS) estimates for American Renal Associates Holdings in a report released on Monday. SunTrust Banks analyst D. Macdonald now forecasts that the firm will post earnings of $0.97 per share for the year, up from their prior forecast of $0.90. SunTrust Banks currently has a “Buy” rating and a $24.00 target price on the stock. SunTrust Banks also issued estimates for American Renal Associates Holdings’ Q4 2016 earnings at $0.26 EPS, Q1 2017 earnings at $0.22 EPS, Q2 2017 earnings at $0.29 EPS, Q3 2017 earnings at $0.32 EPS, Q4 2017 earnings at $0.33 EPS, FY2017 earnings at $1.16 EPS and FY2018 earnings at $1.33 EPS.

Other analysts have also issued reports about the company. Wells Fargo & Co. reissued a “buy” rating on shares of American Renal Associates Holdings in a research note on Sunday, September 25th. Bank of America Corp. reissued a “buy” rating and issued a $35.00 price target on shares of American Renal Associates Holdings in a research note on Monday, August 22nd. Zacks Investment Research raised American Renal Associates Holdings from a “hold” rating to a “buy” rating and set a $26.00 price target on the stock in a research note on Thursday, August 11th. Leerink Swann reissued a “buy” rating on shares of American Renal Associates Holdings in a research note on Thursday, August 11th. Finally, Barclays PLC reaffirmed a “buy” rating and issued a $31.00 price objective on shares of American Renal Associates Holdings in a research note on Thursday, August 18th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $29.50.

Earnings History and Estimates for American Renal Associates Holdings (NYSE:ARA)

Shares of American Renal Associates Holdings (NYSE:ARA) opened at 22.25 on Tuesday. The stock’s market capitalization is $686.81 million. American Renal Associates Holdings has a 1-year low of $16.86 and a 1-year high of $29.65. The company’s 50 day moving average is $18.24 and its 200-day moving average is $23.21.

American Renal Associates Holdings (NYSE:ARA) last released its earnings results on Thursday, November 10th. The company reported $0.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.24 by $0.04. American Renal Associates Holdings had a net margin of 1.92% and a return on equity of 55.06%. The firm had revenue of $192.96 million for the quarter, compared to analyst estimates of $189.73 million. The firm’s revenue was up 14.9% compared to the same quarter last year.

Institutional investors have recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company bought a new position in American Renal Associates Holdings during the third quarter valued at approximately $121,000. Acrospire Investment Management LLC bought a new position in American Renal Associates Holdings during the second quarter valued at approximately $130,000. American International Group Inc. bought a new position in American Renal Associates Holdings during the second quarter valued at approximately $146,000. Nationwide Fund Advisors bought a new position in American Renal Associates Holdings during the second quarter valued at approximately $166,000. Finally, Rhumbline Advisers bought a new position in American Renal Associates Holdings during the second quarter valued at approximately $225,000. 84.13% of the stock is currently owned by hedge funds and other institutional investors.

About American Renal Associates Holdings

American Renal Associates Holdings, Inc is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD).

5 Day Chart for NYSE:ARA

Receive News & Stock Ratings for American Renal Associates Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates Holdings Inc and related stocks with our FREE daily email newsletter.